Jeno Gyuris, Ph.D.

Partner atCure VenturesMassachusetts

Jeno Gyuris is a biotech professional with over thirty years of industry experience. He has held scientific leadership roles at several companies and focuses on translating discoveries into therapies.

What Jeno can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. Mitotix Inc.
  2. AVEO Oncology · Chief Scientific Officer
  3. Sporos Bioventures LLC · Chief Scientific Officer
  4. Tvardi · chief Scientific Officer
  5. Asylia · chief Scientific Officer
  6. Stellanova Therapeutics · chief Scientific Officer
  7. Cure Ventures · Partner
    Now

Companies founded

Sporos Bioventures LLC

Focus

biotechdrug discoverytherapies

Education

University of Szeged, doctorateHarvard Medical School, postdoctoral studiesMassachusetts General Hospital, postdoctoral studiesMax Planck Institute

Also at Cure Ventures

Partners like Jeno

At firms with a similar stage, sector and check size.

Alert me when Cure Ventures is active

One email when Jeno's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Jeno Gyuris, Ph.D.?

Jeno Gyuris is a biotech professional with over thirty years of industry experience. He has held scientific leadership roles at several companies and focuses on translating discoveries into therapies.

How much does Jeno Gyuris, Ph.D. invest?

Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Jeno Gyuris, Ph.D.?

Email [email protected], the firm's inbox for founders, and name Jeno in the subject. A warm intro from a founder Cure Ventures backed works better.

What did Jeno Gyuris, Ph.D. do before Cure Ventures?

Mitotix Inc.; Chief Scientific Officer at AVEO Oncology; Chief Scientific Officer at Sporos Bioventures LLC; chief Scientific Officer at Tvardi; chief Scientific Officer at Asylia; chief Scientific Officer at Stellanova Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.